Porton Pharma Solutions Ltd(300363) received a letter of concern: Shenzhen Stock Exchange asked the company to explain whether the existing capacity can meet the order delivery needs of Pfizer’s companies, whether there is a risk of failure to deliver in time, and whether the relevant capacity planning will have a significant adverse impact on the company’s existing production, operation and performance.
© China Stock Market News